Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
07/13/2005 | CN1637625A Organophotoreceptor with a charge transport material having two epoxidated-hydrazone groups |
07/13/2005 | CN1636993A Process for producing novel form of paroxetine hydrochloride anhydrate |
07/13/2005 | CN1636992A Process for producing quinazoline ditosylate salt compounds |
07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
07/13/2005 | CN1636983A Substituted heterocyclic compounds |
07/13/2005 | CN1636977A 1, 3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
07/13/2005 | CN1210274C Piperazine and piperidine derivatives |
07/13/2005 | CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
07/13/2005 | CN1210029C Pharmaceutical use for piperine and method for cosmetically promoting the natural coloration of the skin |
07/12/2005 | US6916957 Antiinflammatory agents; antihistamines; antiallergens |
07/12/2005 | US6916932 Such as (3S,6S,7R,8R)-8-benzyl-3-(((3-(benzyloxy)-4-methoxypyridin-2 -yl)carbonyl)amino)-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl-2-methylpropanoate for fungicides |
07/12/2005 | US6916926 Process for the preparation of (±) 1-3-dioxolanes and the optical resolution thereof |
07/12/2005 | US6916850 Pyruvate derivatives |
07/12/2005 | US6916847 Anticoagulants; thrombosis; cardiovascular disorders |
07/12/2005 | US6916841 Inhibitors of phospholipase enzymes |
07/12/2005 | US6916830 Substituted tetrahydroisoquinolines as C5a receptor modulators |
07/12/2005 | US6916819 Benzimidazole and pyridylimidazole derivatives |
07/12/2005 | US6916814 Methods of treating cytokine mediated diseases |
07/12/2005 | US6916813 (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase |
07/12/2005 | US6916812 Dietetic agents |
07/12/2005 | US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme |
07/12/2005 | US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use |
07/12/2005 | US6916798 Inhibitors of glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase; for treatment and prevention of diabetes and Alzheimer's disease |
07/07/2005 | WO2005061519A1 Kinase inhibitors |
07/07/2005 | WO2005061487A1 Hiv protease inhibiting compounds |
07/07/2005 | WO2005061484A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
07/07/2005 | WO2005061483A2 Modulators of peripheral 5-ht receptors |
07/07/2005 | WO2005061482A1 Ecstasy haptens and immunogens |
07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
07/07/2005 | WO2005061467A2 Piperazine derivatives as bradykinin antagonists |
07/07/2005 | WO2005061458A2 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
07/07/2005 | WO2005061450A2 Hiv protease inhibiting sulfonamides |
07/07/2005 | WO2005061442A1 Opioid receptor antagonists |
07/07/2005 | WO2005060970A1 Pyrimidines with tie2 (tek) activity |
07/07/2005 | WO2005060969A1 Pyrimidines with tie2 (tek) activity |
07/07/2005 | WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
07/07/2005 | WO2005060663A2 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
07/07/2005 | WO2005047257A3 Methods and compositions for selectin inhibition |
07/07/2005 | WO2005042521A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
07/07/2005 | WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
07/07/2005 | WO2005032471A3 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
07/07/2005 | WO2004098516A3 Cyclic derivatives as modulators of chemokine receptor activity |
07/07/2005 | WO2004082822A3 Methods for isolating crystalline form i of 5-azacytidine |
07/07/2005 | WO2003063771A3 N4-acylcytosine nucleosides for treatment of viral iinfections |
07/07/2005 | WO2003053360A3 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
07/07/2005 | US20050148778 One pot, industrial scale, low cost synthesis; forming diazonium salt of 4-[1,2,4]triazol-1ylmethyl-aniline HCL, reducing, acidifying; reacting intermediate with keto-valerolactone then fischer indole converting followed by transesterification, amination, saponification decarboxylation |
07/07/2005 | US20050148777 (2R)-6-chloro-7-isobutyl-2-(trifluoromethyl)-2H-chromene-3-carboxylic acid; cyclooxygenase-2 mediated disorders |
07/07/2005 | US20050148657 9, 10-Alpha, alpha-OH-taxane analogs and methods for production thereof |
07/07/2005 | US20050148650 protein kinase B activating agents for preventing or treating depression, PTSD, Parkinson's disease, Alzheimer's diseases, and the like; comprises for e.g. [1] 2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]isoindoline |
07/07/2005 | US20050148646 Dicationic triaryl analogs as anti-protozoan agents |
07/07/2005 | US20050148645 Improved solubility in organic solvents, facilitating the separation, purification and identification of the components; antimalarial, an antiproliferative agent, an antifungal agent, an antibacterial, or an anti-inflammatory agent |
07/07/2005 | US20050148635 3-imino-2-indolones for the treatment of depression and/or anxiety |
07/07/2005 | US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals |
07/07/2005 | US20050148627 Benzopyran compounds for use in the treatment and prevention of inflammation related conditions |
07/07/2005 | US20050148623 HIV protease inhibiting compounds |
07/07/2005 | US20050148605 Modulation of protein tyrosine kinases for treatment of diseases with prodrugs |
07/07/2005 | US20050148601 Neurokinin-3 receptor modulators: diaryl imidazole derivatives |
07/07/2005 | US20050148588 LFA-1 antagonist compounds |
07/07/2005 | US20050148581 Quinolines; 1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol; Mycobacterium tuberculosis, M. bovis, M. avium and M. marinum; reduces the total length of treatment and the frequency of drug administration; multi-drug and antibiotic resistance |
07/07/2005 | US20050148574 Imidazole compositions useful as inhibitors of protein kinases |
07/07/2005 | US20050148573 Benzimidazolone compounds having 5-HT4 receptor agonistic activity |
07/07/2005 | US20050148548 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
07/07/2005 | US20050148086 Fluorescent sensor for phosphate ion and phosphorylated peptide |
07/07/2005 | US20050147905 Electrostatics; high compatibility with the polymeric binder, reduced phase separation, and reduced extraction by liquid carriers |
07/07/2005 | CA2792483A1 Hiv protease inhibiting sulfonamides |
07/07/2005 | CA2550643A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
07/07/2005 | CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
07/07/2005 | CA2549389A1 Hiv protease inhibiting sulfonamides |
07/07/2005 | CA2549009A1 Opioid receptor antagonists |
07/07/2005 | CA2548824A1 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
07/07/2005 | CA2529314A1 Piperazine derivatives and methods of use |
07/06/2005 | EP1550914A1 Organophotoreceptor with a charge transport material having two epoxidated-hydrazone groups |
07/06/2005 | EP1550727A1 Novel macrophage foam cell formation inhibitor fka-25 and p rocess for producing the same |
07/06/2005 | EP1550668A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
07/06/2005 | EP1550660A1 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
07/06/2005 | EP1550657A1 Amine compounds and use thereof |
07/06/2005 | EP1549646A2 Piperidine derivatives |
07/06/2005 | EP1549627A1 1-phenylalkyl-piperazines |
07/06/2005 | EP1549621A1 Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes |
07/06/2005 | EP1549619A1 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
07/06/2005 | EP1549614A2 Vasculostatic agents and methods of use thereof |
07/06/2005 | EP1549600A1 Ketones |
07/06/2005 | EP1549316A1 INHIBITORS OF TFG&bgr; |
07/06/2005 | EP1233961B1 Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination |
07/06/2005 | EP1212320B1 Phenylpiperazines as serotonin reuptake inhibitors |
07/06/2005 | EP1140909B1 Novel inhibitors of farnesyl-protein transferase |
07/06/2005 | EP0776327B1 New multimerizing agents |
07/06/2005 | CN1636002A Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide |
07/06/2005 | CN1636001A 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
07/06/2005 | CN1636000A 5-substituted arylpyrimidines |
07/06/2005 | CN1635903A Protease inhibitors |
07/06/2005 | CN1635890A Neuroprotective 2-pyridinamine compositions and related methods |
07/06/2005 | CN1635885A Improvement of nitric oxide synthase activity by using substituted indole compound |
07/06/2005 | CN1635878A Methods of treating cancer and the pain associated therewith with using endothelin antagonists |
07/06/2005 | CN1634893A 4, 5-disubstituted-1, 8-naphthoyl imide compounds and use thereof |
07/06/2005 | CN1209360C 16-halogen-epothilone derivatives, process for producing them and their pharmaceutical use |
07/05/2005 | US6914160 Oxytocin inhibitors |